We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry: ATMP Reg Lacks Flexibility for Evaluating Non-Drug Components
Industry: ATMP Reg Lacks Flexibility for Evaluating Non-Drug Components
June 6, 2013
Six years after the EU’s advanced therapy medicinal products regulation went into effect, only one tissue-engineered product has been granted approval, Eucomed says in comments criticizing the regulation’s approach to the evaluation of ATMP products.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor